Osteotech enters major European tissue recovery deal
This article was originally published in Clinica
Osteotech's French subsidiary has entered a seven-year agreement with the Bulgarian federal agency of transplant management, under which it will recover tissue from up to 56 local hospitals to supply the growing demand for allografts in Europe. Under the deal, the company has been assigned responsibility for how and where to carry out allograft tissue processing and distribution.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.